Sign In
Buy TEM
$50.56
-1.76 (-3.36%)
At Close: Jun 16, 2026
Ryan Fukushima Sells 9,592 Shares of Tempus AI (NASDAQ:TEM) Stock
04:32am, Sunday, 22'nd Feb 2026
Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) CEO Ryan Fukushima sold 9,592 shares of Tempus AI stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $59.05, f
Andrew Polovin Sells 8,143 Shares of Tempus AI (NASDAQ:TEM) Stock
04:32am, Sunday, 22'nd Feb 2026
Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) EVP Andrew Polovin sold 8,143 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average p
AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech
10:06am, Friday, 20'th Feb 2026
TEM rolls out new AI tools across oncology, cardiology and mental health, accelerating its push to reshape MedTech innovation.
Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week
12:04pm, Thursday, 19'th Feb 2026
Tempus AI shares climb after Mizuho's Outperform call and a new HRD-RNA cancer detection algorithm announcement.
Is TEM Stock A Buy At $60?
11:01am, Thursday, 19'th Feb 2026
Tempus AI (NASDAQ: TEM) trades at a premium by traditional metrics, remains unprofitable on a GAAP basis, and has spent the past week benefiting from strong analyst optimism. So why might the stock st
Unlocking Q4 Potential of Tempus (TEM): Exploring Wall Street Estimates for Key Metrics
10:16am, Thursday, 19'th Feb 2026
Get a deeper insight into the potential performance of Tempus (TEM) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Pre-Market Stock Futures: Futures are trading lower on Thursday, as Walmart's forward outlook was disappointing. Risk-on was back on Wednesday, as the stock market, which is off to its worst start of
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week's Earnings
11:52am, Wednesday, 18'th Feb 2026
Tempus AI, Inc. (NASDAQ:TEM) shares are climbing today after the company unveiled a new AI-powered cancer diagnostic algorithm, building momentum ahead of its Q4 2025 earnings report scheduled for Feb
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
10:45am, Wednesday, 18'th Feb 2026
TEM heads into Q4 earnings with expected 82.8% revenue growth, rising oncology momentum and a premium valuation clouding near-term upside.
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
08:30am, Wednesday, 18'th Feb 2026
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of its new HRD-RNA algorithm. This ne
Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel
12:20pm, Tuesday, 17'th Feb 2026
TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.
Market Movers: Citi Bullish on NVDA Heading into Earnings
11:32am, Tuesday, 17'th Feb 2026
NVIDIA (NASDAQ: NVDA) is sinking today. But with earnings just days away, we do expect to see explosive upside. For one, analysts at Citi just reiterated a buy rating on the tech giant. The firm noted
Significant Increase in NVIDIA Corp by Duan Yongping: A 7.08% Portfolio Impact
10:00am, Tuesday, 17'th Feb 2026
Exploring Duan Yongping (Trades, Portfolio)'s Strategic Moves in Q4 2025 Duan Yongping (Trades, Portfolio), a renowned investor known for his strategic and val
Pre-Market Stock Futures: Futures are trading lower as investors and traders return from the three-day holiday break, after a wild week that saw just about everything. The catalyst on Friday was that
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?
10:35am, Friday, 13'th Feb 2026
In preliminary, unaudited financial results, TEM posts 83% revenue growth and record data sales in 2025, but valuation and ongoing GAAP losses cloud the outlook before Q4 earnings.
